Welcome to our dedicated page for Owlet SEC filings (Ticker: OWLT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Owlet, Inc. filings document regulatory disclosures for a public pediatric health technology company whose Class A common stock trades on the New York Stock Exchange under OWLT. Recent Form 8-K reports cover operating results, business updates, executive leadership changes, annual meeting matters and stockholder approval of amendments to the company's equity incentive plan.
The filing record also includes disclosures tied to capital structure and financing activity, including preliminary financial information related to an offering and borrowings under an asset-based revolving credit facility. Other material-event filings document shareholder derivative litigation settlement notices, exchange-listed securities, governance matters and exhibits furnished with earnings releases.
Investment Company, Inc., an investment adviser based in Delaware, reports beneficial ownership of 1,748,251 Owlet Class A common shares, representing 6.3% of the class. The firm has sole voting and dispositive power over these shares through four affiliated investment funds and certifies the holdings are in the ordinary course of business, not intended to change or influence control of Owlet, Inc..
Owlet, Inc. filed an 8-K to note that the court hearing on a proposed settlement of shareholder derivative litigation has been continued to February 25, 2026. The settlement would resolve claims brought on Owlet’s behalf alleging fiduciary and disclosure breaches by former and current directors and officers.
Under the proposed deal, Owlet’s board agrees to adopt and maintain extensive governance and compliance reforms for at least eight years. These include a new board-level Audit and Risk Committee, a management-level Enterprise Risk Management Committee, and a management-level Disclosure Committee focused on accurate SEC and investor communications. The company will also enhance director education and cap outside board seats for independent directors and the chair.
Plaintiffs’ counsel will seek a court-approved fee and expense award of $675,000, from which $2,000 service awards would be paid to each plaintiff. There is no common cash fund for stockholders. Current holders as of April 2, 2025 may object or appear at the hearing by following the detailed procedures and deadlines described in the notice.
Owlet, Inc.'s Chief Financial Officer reports an automatic stock sale related to tax withholding. On January 20, 2026, CFO Amanda Crawford reported the sale of 183 shares of Owlet common stock at $13.33 per share. According to the filing, these shares were automatically sold in a non-discretionary transaction to cover taxes and fees tied to the vesting and settlement of restricted stock units. Following this small sale, Crawford beneficially owned 150,325 shares of Owlet common stock directly.
Owlet, Inc. President and CEO Jonathan Harris reported an automatic sale of 2,311 shares of common stock at $13.33 per share on January 20, 2026. The filing states that these shares were sold in a non-discretionary transaction to cover taxes and fees related to the vesting and settlement of restricted stock units. Following this tax-related sale, Harris beneficially owned 264,396 shares of Owlet common stock in direct ownership.
Owlet, Inc. has registered up to 5,346,194 shares of Class A common stock for resale by existing securityholders. These shares were issued to certain investors in exchange for previously outstanding Series A and Series B warrants under an Exchange Agreement dated August 7, 2025. Owlet will not receive any cash from the resale of these shares; any proceeds will go to the selling stockholders, who will also bear any underwriting discounts and selling commissions.
The exchanged shares are subject to a contractual lockup that generally prevents sales or transfers until April 8, 2026, limiting near-term resale activity. The prospectus also explains Owlet’s capital structure, including authorized common and preferred stock, the terms of its Series A and Series B convertible preferred shares, and governance and anti-takeover provisions that shape voting power, director elections, and potential change-of-control transactions.
Owlet, Inc. has filed a registration statement covering the resale of up to 5,346,194 shares of its Class A common stock by existing securityholders. These shares were issued in exchange for certain Series A and Series B warrants under an August 7, 2025 Exchange Agreement, simplifying the company’s capital structure by replacing warrants with stock.
The company will not receive any proceeds from sales of these shares; all sale proceeds will go to the selling stockholders, who will bear any underwriting discounts and selling commissions, while Owlet covers registration expenses. The registered shares are subject to a contractual lockup that generally restricts sales until April 8, 2026. Owlet’s common stock trades on the NYSE under the symbol “OWLT”, with a last reported price of $11.96 per share on November 20, 2025.
Owlet, Inc. filed a Form S-8 to register 375,000 shares of Class A common stock issuable under its 2021 Incentive Award Plan, as Amended.
The filing relies on General Instruction E to incorporate prior effective S-8 registrations for the plan and includes customary exhibits such as a legal opinion and auditor consent.
Owlet, Inc. filed its Q3 2025 10‑Q reporting stronger top‑line and improved profitability. Revenue reached $31,988 thousand versus $22,122 thousand a year ago, lifting gross profit to $16,200 thousand. Operating income was $1,216 thousand, compared with a loss last year, and net income totaled $4,134 thousand, aided by a common stock warrant liability adjustment.
Cash and cash equivalents were $23,760 thousand. The company reported $18,616 thousand outstanding under its asset‑based line of credit and $7,500 thousand drawn on its WTI term loan. Total liabilities were $113,464 thousand and stockholders’ deficit was $54,143 thousand as of September 30, 2025. As a subsequent event, the company completed an offering of 4,825,400 shares at $7.15 per share, yielding net proceeds of $32,109 thousand. Shares outstanding were 27,580,607 as of November 10, 2025.
The filing states conditions that raise substantial doubt about the company’s ability to continue as a going concern, despite a profitable quarter and the October equity raise.
Owlet, Inc. (OWLT) furnished a press release announcing its financial results for the three months ended September 30, 2025 and noting related management changes. The company provided the release as Exhibit 99.1 to a Form 8-K.
The information was furnished under Item 2.02 and, as stated, is not deemed “filed” under the Exchange Act. The filing also lists the cover page Inline XBRL data as Exhibit 104. Owlet’s Class A common stock trades on the NYSE under the symbol OWLT, and the company is identified as an emerging growth company.
Owlet, Inc. launched an underwritten public offering of 4,196,000 shares of Class A common stock at $7.15 per share, with a 30‑day option for underwriters to purchase up to 629,400 additional shares. The company said it intends to use the net proceeds to support continued commercialization, research and development, and for general corporate purposes. Directors, executive officers, and certain stockholders agreed to a 90‑day lock‑up after the date of the final prospectus.
Owlet also provided preliminary unaudited third‑quarter 2025 results: revenue is estimated at $30 million to $32 million, up from $22.1 million a year ago. Estimated gross margin is approximately 49.5%–51% versus 52.2% in the prior‑year period, which the company believes reflects tariff impacts on cost of goods sold. Cash and cash equivalents were approximately $23.8 million as of September 30, 2025 and include about $18.6 million in additional borrowings during the quarter under its asset‑based revolving credit facility.